"Pelik\u00E1nov\u00E1, Terezie" . . "Fatty acid binding proteins in adipose tissue: a promising link between metabolic syndrome and atherosclerosis?"@en . . "2"^^ . "Adipocyte/macrophage fatty acid binding protein has been shown to be closely associated with metabolic syndrome, obesity and development of atherosclerosis. Moreover, A-FABP has been recently suggested as a potential therapeutic target of these abnormalities in animal models. The present review aims to summarize current knowledge on A-FABP functions and regulations both in animal models and humans, since the role of A-FABP in human physiology and disease has not been presently clarified." . "8"^^ . . "[FF5D6D0E2006]" . "2"^^ . . "Diabetes research and clinical practice" . . . . . "82" . . "RIV/00023001:_____/08:00001889!RIV09-MZ0-00023001" . "metabolic syndrome; atherosclerosis; FABP; adipose tissue"@en . "Vazebn\u00E9 b\u00EDlkoviny FABP pro mastn\u00E9 kyseliny v tukov\u00E9 tk\u00E1ni, nad\u011Bjn\u00E9 poj\u00EDtko mezi metabolick\u00FDm syndromem a aterosklerozou?"@cs . "Fatty acid binding proteins in adipose tissue: a promising link between metabolic syndrome and atherosclerosis?" . "Fatty acid binding proteins in adipose tissue: a promising link between metabolic syndrome and atherosclerosis?" . . "0168-8227" . "Fatty acid binding proteins in adipose tissue: a promising link between metabolic syndrome and atherosclerosis?"@en . "P(NR8991)" . "Vazebn\u00E9 b\u00EDlkoviny FABP pro mastn\u00E9 kyseliny v tukov\u00E9 tk\u00E1ni, nad\u011Bjn\u00E9 poj\u00EDtko mezi metabolick\u00FDm syndromem a aterosklerozou?"@cs . . "suppl. 2" . . "000262141300009" . "RIV/00023001:_____/08:00001889" . . "367735" . . . . . "Adipocyte/macrophage fatty acid binding protein has been shown to be closely associated with metabolic syndrome, obesity and development of atherosclerosis. Moreover, A-FABP has been recently suggested as a potential therapeutic target of these abnormalities in animal models. The present review aims to summarize current knowledge on A-FABP functions and regulations both in animal models and humans, since the role of A-FABP in human physiology and disease has not been presently clarified."@en . "Kru\u0161inov\u00E1, Eva" . "Vazebn\u00E9 b\u00EDlkoviny pro mastn\u00E9 kyseliny v adipocytech a makrof\u00E1z\u00EDch jsou asociovan\u00E9 s metabolick\u00FDm syndromem, obezitou a rozvojem aterosklerozy. Zv\u00ED\u0159ec\u00ED modely ukazuj\u00ED, \u017Ee l\u00E9\u010Debn\u00E9 intervence zam\u011B\u0159en\u00E9 na FABP jsou nad\u011Bjn\u00E9. Sd\u011Blen\u00ED shrnuje sou\u010Dasn\u00E9 znalosti o FABP, jeho funkc\u00EDch, regulac\u00EDch, v experiment\u00E1ln\u00EDch modelech i u \u010Dlov\u011Bka."@cs . "NL - Nizozemsko" .